The impact of clinical pharmacist and ID intervention in rationalization of antimicrobial use

Publication date: December 2014 Source:Saudi Pharmaceutical Journal, Volume 22, Issue 6 Author(s): Niaz Al-Somai , Mohammed Al-Muhur , Osama Quteimat , Nashaat Hamzah What is known and objective There is little research on the impact of implementing and monitoring antimicrobial policy in Saudi hospitals. The purpose of this study is to measure the impact of the clinical pharmacist (CP) and infectious disease consultant (ID) interventions on the use of three antimicrobials (caspofungin, imipenem, meropenem) in hospitalized patients in the King Abdullah Medical City hospital. Methods The study was carried out in the King Abdullah Medical City, in Mekkah, Saudi Arabia. The hospital is a tertiary center that provides CCU, CSICU, Cardiac, Hematology, ICU, Medical, Neuroscience, Oncology, and specialized surgery services. The use of three antimicrobials (caspofungin, imipenem, meropenem) was reviewed by the clinical pharmacist for four periods, pre and post implementation of policy. Relevant data were collected in four periods. In the first period, before policy implementation, data were collected retrospectively to be used as baseline status reference, and in the three remaining periods that followed data were collected prospectively, and compared to baseline data, to evaluate the role of clinical pharmacist and ID interventions in optimizing antimicrobial therapy. Results and discussion Caspofungin duration of therapy was not affected significantly by the intervention...
Source: Saudi Pharmaceutical Journal - Category: Drugs & Pharmacology Source Type: research